Table 1 Summary of study characteristics
Author | BAV (N) | TAV (N) | Age (years) | P | Gender (male, %) | P | ||
|---|---|---|---|---|---|---|---|---|
BAV | TAV | BAV | TAV | |||||
Aicher 2007 | 81 | 193 | 52 ± 12 | 62 ± 15 |  < 0.001 | 69, 85.2% | 132, 68.4% | 0.004 |
Carlos 2017 | 57 | 103 | 46.0 ± 11.8 | 57.5 ± 17.8 | 0.001 | 57, 100% | 89, 88.1% | 0.005 |
Dainius 2019 | 29 | 63 | 42.4 ± 12 | 55.3 ± 14.9 | 0.001 | 56, 88.9% | 27, 93.1% | 0.5 |
Hans 2015 | 290 | 431 | 54 ± 15 |  |  | – | – |  |
John 2012 | 63 | 170 | 43 ± 12 | 36 ± 13 |  < 0.001 | 50, 79.4% | 115, 67.6% | 0.08 |
Joseph 2015 | 40 | 89 | 46 ± 12 | 45 ± 15 | 0.7 | 35, 87.5% | 63, 70.8% | 0.3 |
Malakh 2017 | 24 | 173 | 40(30–47) | 49(35–62) | 0.0051 | 21, 87.5% | 123, 71.1% | 0.72 |
Maral 2018 | 45 | 135 | 40 ± 13 | 41 ± 14 | 0.93 | 121, 89.6% | 39, 86.7% | 0.59 |
Pietro 2012 | 24 | 108 | – | – |  | – | – |  |
Shunsuke 2020 | 414 | 589 | – | – |  | – | – |  |
Suyog 2020 | 71 | 71 | 48 ± 12 | 49 ± 12 |  | 57, 80.3% | 52, 73.2% |  |
Author | Country | Study period | Follow-up duration (years) |
|---|---|---|---|
(a) | Â | Â | Â |
Aicher 2007 | Germany | October 1995–October 2006 | 10 |
Carlos 2017 | Spain | March 2004–December 2015 | 5 |
Dainius 2019 | Lithuania | April 2004–October 2016 | 10 |
Hans 2015 | Spain | October 1995–December 2013 | 15 |
John 2012 | America | 1993–2009 | 10 |
Joseph 2015 | America | 2004–2013 | 5 |
Malakh 2017 | Germany | 1993–2015 | 8.7 |
Maral 2018 | Canada | 1988–2012 | 8.2 |
Pietro 2012 | Italy | 2002–2011 | 5 |
Shunsuke 2020 | Germany | 1995–2018 | 15 |
Suyog 2020 | America | January 2002–July 2017 | 8 |
Author | BAV | TAV | Preoperative degree of AR | LV EF (%) | Marfan | Aortic dissection | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
(N) | (N) | I | II | III | IV | BAV | TAV | BAV | TAV | BAV | TAV | |
(b) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Aicher 2007 | 81 | 193 | 71 | 64 | 116 | 23 | – | – | 0 | 5 | 6 | 40 |
Carlos 2017 | 57 | 103 | 224 | 37 | 3 | 3 | 85.4% EF ≥ 55% | 107 | 7 | |||
Dainius 2019 | 29 | 63 | 5 | 47 | 38 | 2 | 53.6 ± 7.5 | 48.7 ± 10.1 | – | – | 1 | 6 |
Hans 2015 | 290 | 431 | 56 | 183 | 436 | 21 | – | – | 29 | 59 | ||
John 2012 | 63 | 170 | 89 | 64 | 52 | 28 | 62 | 61 | 3 | 91 | 0 | 0 |
Joseph 2015 | 40 | 89 | 19 | 38 | 20 | 28 | 58 ± 9 | 56 ± 10 | 0 | 47 | – | – |
Malakh 2017 | 24 | 173 | 21 | 29 | 50 | 97 | – | – | 60 |  | – | – |
Maral 2018 | 45 | 135 | – | – | – | – | 75% EF ≥ 60% | 4 | 71 | – | – | |
Pietro 2012 | 24 | 108 | – | – | – | – | 88% EF > 45% | 5 | 1 | |||
Shunsuke 2020 | 414 | 589 | – | – | – | – | – | – | – | – | 73 | |
Suyog 2020 | 71 | 71 | 58 | 33 | 29 | 22 | 57 ± 5.4 | 57 ± 5.6 | – | – | 0 | 1 |
Author | BAV | TAV | Prolapse correction | |
|---|---|---|---|---|
(N) | (N) | BAV | TAV | |
(c) | Â | Â | Â | Â |
Aicher 2007 | 81 | 193 | 70 | 103 |
Carlos 2017 | 57 | 103 | 47 | 56 |
Dainius 2019 | 29 | 63 | 28 | 53 |
Hans 2015 | 290 | 431 | – | – |
John 2012 | 63 | 170 | 42 | 63 |
Joseph 2015 | 40 | 89 | 40 | 13 |
Malakh 2017 | 24 | 173 | 11 | 14 |
Maral 2018 | 45 | 135 | 42 | 59 |
Pietro 2012 | 24 | 108 | 10 | 3 |
Shunsuke 2020 | 414 | 589 | – | – |
Suyog 2020 | 71 | 71 | – | – |